MRK vs AMGN — Key Metrics

Metric MRK (MERCK & CO INC) AMGN (AMGEN INC)
Price137.78443.89
Market Cap339.66 Billion240.11 Billion
P/E (TTM)137.7825.54
P/B (Quarterly)8.25718.033
P/S (TTM)5.046.17
Net Profit Margin (TTM)3.624.1
Gross Margin (TTM)71.870.9
ROE (TTM)5.385.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

MERCK & CO INC
vs
 
AMGEN INC
 
MERCK & CO INC
vs
 
AMGEN INC
Performance Comparison
AI Model Recommendation
MRK · MERCK & CO INC

Greatly Outperform

82
UnderperformOutperform
AMGN · AMGEN INC

Outperform

38
UnderperformOutperform
Recommendation Summary

Stock MRK is projected to greatly outperform the market, stock AMGN is projected to outperform the market. Upfront Recommendation: MRK.

Financial Metrics
Prices delayed ~15 min
MRK Metrics AMGN
$137.78 Price $443.89
— Market Capitalization —
137.78 Price to Earnings Ratio 25.54
5.04 Price to Sales 6.17
23.03 Price to FCF Ratio 25.06
7.03 Price to Gross Profit 8.7
11.04 Price to R&D 30.63
8.72 Price to Current Assets 6.99

MRK vs AMGN at a glance

Merck & CO INC (MRK) and Amgen INC (AMGN) are both Drug Manufacturers - General companies in the Healthcare sector. MRK is the larger, at $339.7 billion in market value against $240.1 billion for AMGN, about 1.4 times the size.

On trailing-twelve-month figures, MRK trades at 137.8 times trailing earnings and AMGN at 25.5; net profit margins are 3.6% and 24.1%.

The Upfront Investment model currently rates MRK Greatly Outperform and AMGN Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.